Impact on clinical status and quality of life of switching from regular insulin to insulin lispro among patients using insulin pumps.
Campbell
R K
RK
The College of Pharmacy. Washington State University, Pullman, Washington (Mr Campbell, Drs Sclar and Stowers, Ms Robison)
Sclar
D A
DA
The College of Pharmacy. Washington State University, Pullman, Washington (Mr Campbell, Drs Sclar and Stowers, Ms Robison)
Robison
L M
LM
The College of Pharmacy. Washington State University, Pullman, Washington (Mr Campbell, Drs Sclar and Stowers, Ms Robison)
Stowers
J K
JK
The College of Pharmacy. Washington State University, Pullman, Washington (Mr Campbell, Drs Sclar and Stowers, Ms Robison)
Ferguson
J C
JC
The Division of Endocrinology and Metabolism, Mount Sinai Hospital. University of Toronto, Toronto, Ontario, Canada (Ms Ferguson)
Trippe
B S
BS
Endocrinology Associates of Montgomery, Montgomery, Alabama (Dr Trippe)
Kayne
D M
DM
The Medical Group of Encino, Encino, California (Dr Kayne)
D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000378:metabolism / Q000523:psychology*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007260:Infusion Pumps; D007328:Insulin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D061268:Insulin Lispro; D008297:Male; D011788:Quality of Life; D011795:Surveys and Questionnaires
D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro